Antiviral therapy. Varicella-zoster virus infections, herpes labialis and mucocutaneous herpes, and cytomegalovirus infections.
D000212:Acyclovir / Q000008:administration & dosage; D000284:Administration, Oral; D000287:Administration, Topical; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002644:Chickenpox / Q000188:drug therapy*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D006560:Herpes Labialis / Q000188:drug therapy*; D006561:Herpes Simplex / Q000188:drug therapy*; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007114:Immunization; D007273:Injections, Intramuscular; D007370:Interferon Type I / Q000008:administration & dosage; D014740:Vidarabine / Q000008:administration & dosage
D000998:Antiviral Agents; D007370:Interferon Type I; D014740:Vidarabine; D000212:Acyclovir